Randomized, open-label, comparative trial to evaluate the effects on ovarian function of a monophasic combined oral contraceptive (COC) containing 2.5 mg nomegestrol acetate (NOMAC) and 1.5 mg estradiol (E2), compared to a monophasic COC containing 3 mg drospirenone (DRSP) and 30 microg ethinyl estradiol (EE)
Phase of Trial: Phase III
Latest Information Update: 17 Dec 2014
At a glance
- Drugs Drospirenone/ethinylestradiol; Estradiol/nomegestrol
- Indications Pregnancy
- Focus Pharmacodynamics
- 18 Aug 2008 Actual end date changed from Apr 2008 to Jan 2008 as reported by ClinicalTrials.gov.
- 24 Jan 2008 The expected completion date for this trial is now 1 Feb 2008.
- 22 Aug 2007 New trial record.